{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:39:18Z","timestamp":1793612358841,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mitochondria are the main consumers of oxygen within the cell. How mitochondria sense oxygen levels remains unknown. Here we show an oxygen-sensitive regulation of TFAM, an activator of mitochondrial transcription and replication, whose alteration is linked to tumours arising in the von Hippel\u2013Lindau syndrome. TFAM is hydroxylated by EGLN3 and subsequently bound by the von Hippel\u2013Lindau tumour-suppressor protein, which stabilizes TFAM by preventing mitochondrial proteolysis. Cells lacking wild-type\n                    <jats:italic>VHL<\/jats:italic>\n                    or in which EGLN3 is inactivated have reduced mitochondrial mass. Tumorigenic\n                    <jats:italic>VHL<\/jats:italic>\n                    variants leading to different clinical manifestations fail to bind hydroxylated TFAM. In contrast, cells harbouring the Chuvash polycythaemia\n                    <jats:italic>VHL<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>R200W<\/jats:italic>\n                    <\/jats:sup>\n                    mutation, involved in hypoxia-sensing disorders without tumour development, are capable of binding hydroxylated TFAM. Accordingly, VHL-related tumours, such as pheochromocytoma and renal cell carcinoma cells, display low mitochondrial content, suggesting that impaired mitochondrial biogenesis is linked to VHL tumorigenesis. Finally, inhibiting proteolysis by targeting LONP1 increases mitochondrial content in VHL-deficient cells and sensitizes therapy-resistant tumours to sorafenib treatment. Our results offer pharmacological avenues to sensitize therapy-resistant VHL tumours by focusing on the mitochondria.\n                  <\/jats:p>","DOI":"10.1038\/s42255-022-00593-x","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:11:00Z","timestamp":1656331860000},"page":"739-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel\u2013Lindau syndrome"],"prefix":"10.1038","volume":"4","author":[{"given":"Shuijie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5411-2185","authenticated-orcid":false,"given":"Petra","family":"Bullova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-6990","authenticated-orcid":false,"given":"Jieyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuepei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-2877","authenticated-orcid":false,"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Plescher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar C.","family":"Bedoya-Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R.","family":"Jannig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Valente-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-7792","authenticated-orcid":false,"given":"Marie Arsenian","family":"Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman A.","family":"Zubarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Smed-S\u00f6rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-7568","authenticated-orcid":false,"given":"Carolyn K.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1110-2606","authenticated-orcid":false,"given":"Jorge L.","family":"Ruas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-9081","authenticated-orcid":false,"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-8573","authenticated-orcid":false,"given":"Alex","family":"von Kriegsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1308-0065","authenticated-orcid":false,"given":"Yihai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-3771","authenticated-orcid":false,"given":"Susanne","family":"Schlisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"593_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u2013275 (1999).","journal-title":"Nature"},{"key":"593_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr.","year":"2008","unstructured":"Kaelin, W. G. Jr. The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer. Nat. Rev. Cancer 8, 865\u2013873 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"593_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr.","year":"2008","unstructured":"Kaelin, W. G. Jr. & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393\u2013402 (2008).","journal-title":"Mol. Cell"},{"key":"593_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccr.2007.04.001","volume":"11","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407\u2013420 (2007).","journal-title":"Cancer Cell"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr.","year":"2008","unstructured":"Kaelin, W. G. Jr. The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer. Nat. Rev. 8, 865\u2013873 (2008).","journal-title":"Nat. Rev."},{"key":"593_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang, Z. et al. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N. Engl. J. Med. 367, 922\u2013930 (2012).","journal-title":"N. Engl. J. Med."},{"key":"593_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11060-015-1983-y","volume":"126","author":"D Taieb","year":"2016","unstructured":"Taieb, D. et al. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas. J. Neurooncol. 126, 473\u2013481 (2016).","journal-title":"J. Neurooncol."},{"key":"593_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1530\/ERC-13-0101","volume":"20","author":"RA Toledo","year":"2013","unstructured":"Toledo, R. A. et al. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr. Relat. Cancer 20, 349\u2013359 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"593_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","volume":"10","author":"MA Hoffman","year":"2001","unstructured":"Hoffman, M. A. et al. von Hippel\u2013Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum. Mol. Genet. 10, 1019\u20131027 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","volume":"10","author":"SC Clifford","year":"2001","unstructured":"Clifford, S. C. et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumorigenesis in von Hippel\u2013Lindau disease. Hum. Mol. Genet. 10, 1029\u20131038 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"593_CR11","first-page":"298","volume":"128","author":"WG Kaelin Jr.","year":"2017","unstructured":"Kaelin, W. G. Jr. The VHL tumor suppressor gene: insights into oxygen sensing and cancer. Trans. Am. Clin. Climatol. Assoc. 128, 298\u2013307 (2017).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.onc.1210709","volume":"27","author":"G Kurban","year":"2008","unstructured":"Kurban, G. et al. Collagen matrix assembly is driven by the interaction of von Hippel\u2013Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2. Oncogene 27, 1004\u20131012 (2008).","journal-title":"Oncogene"},{"key":"593_CR13","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1074\/jbc.M611648200","volume":"282","author":"A Grosfeld","year":"2007","unstructured":"Grosfeld, A. et al. Interaction of hydroxylated collagen IV with the von Hippel\u2013Lindau tumor suppressor. J. Biol. Chem. 282, 13264\u201313269 (2007).","journal-title":"J. Biol. Chem."},{"key":"593_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","volume":"1","author":"M Ohh","year":"1998","unstructured":"Ohh, M. et al. The von Hippel\u2013Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell 1, 959\u2013968 (1998).","journal-title":"Mol. Cell"},{"key":"593_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1006\/bbrc.1999.1347","volume":"263","author":"H Okuda","year":"1999","unstructured":"Okuda, H. et al. Direct interaction of the \u03b2-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes. Biochem. Biophys. Res. Commun. 263, 491\u2013497 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"593_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aad5755","volume":"353","author":"J Guo","year":"2016","unstructured":"Guo, J. et al. pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science 353, 929\u2013932 (2016).","journal-title":"Science"},{"key":"593_CR17","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.molcel.2020.01.009","volume":"77","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Genome-wide screening identifies SFMBT1 as an oncogenic driver in cancer with VHL loss. Mol. Cell 77, 1294\u20131306 (2020).","journal-title":"Mol. Cell"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/2159-8290.CD-19-0837","volume":"10","author":"L Hu","year":"2020","unstructured":"Hu, L. et al. TBK1 is a synthetic lethal target in cancer with VHL loss. Cancer Discov. 10, 460\u2013475 (2020).","journal-title":"Cancer Discov."},{"key":"593_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aap8411","volume":"361","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science 361, 290\u2013295 (2018).","journal-title":"Science"},{"key":"593_CR20","doi-asserted-by":"publisher","first-page":"16997","DOI":"10.1073\/pnas.1900748116","volume":"116","author":"S Li","year":"2019","unstructured":"Li, S. et al. EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance. Proc. Natl Acad. Sci. USA 116, 16997\u201317006 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"593_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ng1019","volume":"32","author":"SO Ang","year":"2002","unstructured":"Ang, S. O. et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32, 614\u2013621 (2002).","journal-title":"Nat. Genet."},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1182\/blood-2003-07-2535","volume":"103","author":"VR Gordeuk","year":"2004","unstructured":"Gordeuk, V. R. et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103, 3924\u20133932 (2004).","journal-title":"Blood"},{"key":"593_CR23","first-page":"3879","volume":"117","author":"MM Hickey","year":"2007","unstructured":"Hickey, M. M., Lam, J. C., Bezman, N. A., Rathmell, W. K. & Simon, M. C. von Hippel\u2013Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2\u03b1 signaling and splenic erythropoiesis. J. Clin. Invest. 117, 3879\u20133889 (2007).","journal-title":"J. Clin. Invest."},{"key":"593_CR24","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2010-12-327569","volume":"117","author":"J Bond","year":"2011","unstructured":"Bond, J. et al. Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension. Blood 117, 3699\u20133701 (2011).","journal-title":"Blood"},{"key":"593_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang, H. & Ward, W. F. PGC-1alpha: a key regulator of energy metabolism. Adv. Physiol. Educ. 30, 145\u2013151 (2006).","journal-title":"Adv. Physiol. Educ."},{"key":"593_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.545","volume":"6","author":"H Nilsson","year":"2015","unstructured":"Nilsson, H. et al. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-bromopyruvate. Cell Death Dis. 6, e1585 (2015).","journal-title":"Cell Death Dis."},{"key":"593_CR27","doi-asserted-by":"publisher","first-page":"ra33","DOI":"10.1126\/scisignal.2000444","volume":"2","author":"L Xie","year":"2009","unstructured":"Xie, L. et al. Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci. Signal. 2, ra33 (2009).","journal-title":"Sci. Signal."},{"key":"593_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature07206","volume":"454","author":"C Handschin","year":"2008","unstructured":"Handschin, C. & Spiegelman, B. M. The role of exercise and PGC1\u03b1 in inflammation and chronic disease. Nature 454, 463\u2013469 (2008).","journal-title":"Nature"},{"key":"593_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cell.2017.10.036","volume":"171","author":"HS Hillen","year":"2017","unstructured":"Hillen, H. S., Morozov, Y. I., Sarfallah, A., Temiakov, D. & Cramer, P. Structural basis of mitochondrial transcription initiation. Cell 171, 1072\u20131081(2017).","journal-title":"Cell"},{"key":"593_CR30","first-page":"2816","volume":"60","author":"YH Shiao","year":"2000","unstructured":"Shiao, Y. H., Resau, J. H., Nagashima, K., Anderson, L. M. & Ramakrishna, G. The von Hippel\u2013Lindau tumor suppressor targets to mitochondria. Cancer Res. 60, 2816\u20132819 (2000).","journal-title":"Cancer Res."},{"key":"593_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2012.10.023","volume":"49","author":"B Lu","year":"2013","unstructured":"Lu, B. et al. Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol. Cell 49, 121\u2013132 (2013).","journal-title":"Mol. Cell"},{"key":"593_CR32","doi-asserted-by":"publisher","first-page":"18410","DOI":"10.1073\/pnas.1008924107","volume":"107","author":"Y Matsushima","year":"2010","unstructured":"Matsushima, Y., Goto, Y. & Kaguni, L. S. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc. Natl Acad. Sci. USA 107, 18410\u201318415 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"593_CR33","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1158\/0008-5472.CAN-14-1161","volume":"74","author":"S Couve","year":"2014","unstructured":"Couve, S. et al. Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis. Cancer Res. 74, 6554\u20136564 (2014).","journal-title":"Cancer Res."},{"key":"593_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ncb2531","volume":"14","author":"M Agathocleous","year":"2012","unstructured":"Agathocleous, M. et al. Metabolic differentiation in the embryonic retina. Nat. Cell Biol. 14, 859\u2013864 (2012).","journal-title":"Nat. Cell Biol."},{"key":"593_CR35","doi-asserted-by":"publisher","unstructured":"Zheng, X. et al. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation. Elife https:\/\/doi.org\/10.7554\/eLife.13374 (2016).","DOI":"10.7554\/eLife.13374"},{"key":"593_CR36","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","volume":"73","author":"LA Greene","year":"1976","unstructured":"Greene, L. A. & Tischler, A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424\u20132428 (1976).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"593_CR37","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1083\/jcb.78.3.747","volume":"78","author":"LA Greene","year":"1978","unstructured":"Greene, L. A. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78, 747\u2013755 (1978).","journal-title":"J. Cell Biol."},{"key":"593_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/PAP.0b013e31825c6bc6","volume":"19","author":"JA Barletta","year":"2012","unstructured":"Barletta, J. A. & Hornick, J. L. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications. Adv. Anat. Pathol. 19, 193\u2013203 (2012).","journal-title":"Adv. Anat. Pathol."},{"key":"593_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/376435","volume":"73","author":"JR Toro","year":"2003","unstructured":"Toro, J. R. et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am. J. Hum. Genet. 73, 95\u2013106 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"593_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward, P. S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225\u2013234 (2010).","journal-title":"Cancer Cell"},{"key":"593_CR41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.molcel.2014.12.023","volume":"57","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Mol. Cell 57, 662\u2013673 (2015).","journal-title":"Mol. Cell"},{"key":"593_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.pathol.2.010506.092049","volume":"2","author":"WG Kaelin","year":"2007","unstructured":"Kaelin, W. G. Von Hippel\u2013Lindau disease. Annu Rev. Pathol. 2, 145\u2013173 (2007).","journal-title":"Annu Rev. Pathol."},{"key":"593_CR43","first-page":"4101","volume":"82","author":"H Brauch","year":"1997","unstructured":"Brauch, H. et al. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene. J. Clin. Endocrinol. Metab. 82, 4101\u20134104 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"593_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMoa073123","volume":"358","author":"MJ Percy","year":"2008","unstructured":"Percy, M. J. et al. A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N. Engl. J. Med. 358, 162\u2013168 (2008).","journal-title":"N. Engl. J. Med."},{"key":"593_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature19796","volume":"539","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539, 112\u2013117 (2016).","journal-title":"Nature"},{"key":"593_CR46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"593_CR47","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"593_CR48","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1101\/gad.1648608","volume":"22","author":"S Schlisio","year":"2008","unstructured":"Schlisio, S. et al. The kinesin KIF1B\u03b2 acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 22, 884\u2013893 (2008).","journal-title":"Genes Dev."},{"key":"593_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ncb1699","volume":"10","author":"AP Young","year":"2008","unstructured":"Young, A. P. et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat. Cell Biol. 10, 361\u2013369 (2008).","journal-title":"Nat. Cell Biol."},{"key":"593_CR50","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1101\/gad.297077.117","volume":"31","author":"SM Fell","year":"2017","unstructured":"Fell, S. M. et al. Neuroblast differentiation during development and in neuroblastoma requires KIF1B\u03b2-mediated transport of TRKA. Genes Dev. 31, 1036\u20131053 (2017).","journal-title":"Genes Dev."},{"key":"593_CR51","doi-asserted-by":"publisher","unstructured":"Welander, J. et al. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. J. Clin. Endocrinol. Metab. https:\/\/doi.org\/10.1210\/jc.2013-4375 (2014).","DOI":"10.1210\/jc.2013-4375"},{"key":"593_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.devcel.2015.12.029","volume":"36","author":"S Li","year":"2016","unstructured":"Li, S. et al. The 1p36 tumor suppressor KIF1B\u03b2 is required for calcineurin activation, controlling mitochondrial fission and apoptosis. Dev. Cell 36, 164\u2013178 (2016).","journal-title":"Dev. Cell"},{"key":"593_CR53","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.celrep.2016.02.043","volume":"14","author":"J Rodriguez","year":"2016","unstructured":"Rodriguez, J. et al. Substrate-trapped interactors of PHD3 and FIH cluster in distinct signaling pathways. Cell Rep. 14, 2745\u20132760 (2016).","journal-title":"Cell Rep."},{"key":"593_CR54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","volume":"8","author":"S Lee","year":"2005","unstructured":"Lee, S. et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8, 155\u2013167 (2005).","journal-title":"Cancer Cell"},{"key":"593_CR55","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1093\/nar\/gkq1224","volume":"39","author":"M Minczuk","year":"2011","unstructured":"Minczuk, M. et al. TEFM (c17orf42) is necessary for transcription of human mtDNA. Nucleic Acids Res. 39, 4284\u20134299 (2011).","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1038\/s42255-022-00651-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000}}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00593-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:30:20Z","timestamp":1757100620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-022-00593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1038\/s42255-022-00593-x","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the name of Christofer C. Juhlin was listed incorrectly in the article metadata, which is now updated in the online version of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s42255-022-00651-4","URL":"https:\/\/doi.org\/10.1038\/s42255-022-00651-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}